SCHEMBL3484590

SCHEMBL3484590

CC(C)(C)OC(=O)C(C)(C)Oc1ccc(Sc2ccc(CBr)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 11/20 0.42
PPARG P37231 9/20 0.42
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
TSHR P16473 3/20 0.40
ABCB11 O95342 2/20 0.40
HTR2A P28223 2/20 0.40
PMP22 Q01453 2/20 0.40
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
CYP2C19 P33261 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP2D6 P10635 1/20 0.35
ELANE P08246 1/20 0.35
LMNA P02545 3/20 0.35
CYP2C9 P11712 2/20 0.35
BLM P54132 2/20 0.35
PPARD Q03181 3/20 0.34
TBXAS1 P24557 1/20 0.34
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3483947 0.88 PPARG (0.38) PPARAPPARGPPARD
SCHEMBL3484260 0.87 PPARG (0.47) PPARAPPARGCYP1A2CYP3A4TSHR
SCHEMBL4033117 0.85 PPARA (0.60) PPARAPPARGCYP1A2CYP3A4TSHR
SCHEMBL13539629 0.83 PPARA (0.43) PPARAPPARGCYP1A2CYP3A4TSHR
SCHEMBL3484606 0.81 MMP2 (0.44) PPARAPPARGCYP1A2CYP3A4TSHR
SCHEMBL318984 0.78 PPARG (0.68) PPARAPPARGCYP1A2CYP3A4TSHR
SCHEMBL14122275 0.78 PPARA (0.50) PPARAPPARGCYP1A2CYP3A4TSHR
SCHEMBL3484402 0.78 PPARG (0.44) PPARAPPARGCYP2C9PPARDSMN1; SMN2
SCHEMBL6950141 0.77 PPARA (0.41) PPARAPPARGCYP1A2CYP3A4TSHR
SCHEMBL7094947 0.77 PPARG (0.49) PPARAPPARGCYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES GENFIT (FR) 2010-01-07 US disclosed
WO-2008012470-A2 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATION AND USES GENFIT (FR) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004159-A1 SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES IPO5, PPIP5K2, IPO4 PPARA 1045/4885PPARG 422/4885CYP1A2 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.